Integrated DNA Technologies acquires Archer™ next generation sequencing research assays to advance actionable scientific discoveries.

The power of whole exome sequencing to unravel the cause of rare disease

In this webinar series, Dr. Matthias Begemann and Dr. Florian Kraft walk us through how their team at RWTH Aachen University leveraged IDT’s xGen Exome Panel to advance their rare disease research studies.

Published on: November 03, 2022

Categories:

Next generation sequencing Methods Whole Exome Sequencing Webinar

*RUO—For research use only. Not for use in diagnostic procedures. Unless otherwise agreed to in writing, IDT does not intend for these products to be used in clinical applications and does not warrant their fitness or suitability for any clinical diagnostic use. Purchaser is solely responsible for all decisions regarding the use of these products and any associated regulatory or legal obligations.